The CDC has updated its HIV testing guidance, emphasizing routine, opt-out screening for patients aged 13–64 and more frequent testing for those at higher risk. The approach aims to reduce stigma, ...

As part of a years-long effort by PrEP4ALL and other HIV groups to get Gilead Sciences, a pharmaceutical company, to lower ...

The Centers for Disease Control and Prevention on Friday is scrubbing a swath of HIV-related content from the agency’s website as a part of President Donald Trump’s broader effort to wipe out ...

Deploying lenacapavir will require rethinking who delivers HIV prevention, how it is financed, and what policy infrastructure must be built, and rebuilt, to match the science.

The Trump administration’s newly proposed HIV funding cuts could threaten the health of thousands of Americans, researchers at the Johns Hopkins School of Medicine have warned. If the $1.5 billion ...

A new study in Health Economics suggests the advent of highly active antiretroviral therapy (HAART) for HIV in 1996 may have ...